SIBN analyst estimates
SI-BONE (SIBN) analyst ratings, the average price target and its range, and every firm's latest call.
SIBN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 4, 2026 | UBS | SI-Bone price target raised to $25 from $24 at UBS | $25.00 |
| Jul 28, 2026 | UBS | SI-Bone initiated with a Buy at UBS | $24.00 |
| Jul 16, 2026 | Truist Financial | SI-Bone price target raised to $21 from $18 at Truist | $21.00 |
| Feb 24, 2026 | Truist Financial | SI-Bone price target raised to $24 from $23 at Truist | $24.00 |
| Dec 18, 2025 | Truist Financial | SI-Bone price target raised to $23 from $21 at Truist | $23.00 |
| Dec 17, 2025 | Canaccord Genuity | SI-Bone price target raised to $27 from $26 at Canaccord | $27.00 |
| Dec 16, 2025 | Needham | SI-BONE Inc. (SIBN) PT Raised to $27 at Needham, Added To Conviction List | $27.00 |
| Dec 2, 2025 | Morgan Stanley | SI-Bone price target raised to $23 from $20 at Morgan Stanley | $23.00 |
| Oct 15, 2025 | Truist Financial | SI-Bone price target lowered to $20 from $22 at Truist | $20.00 |
| Aug 11, 2025 | Cantor Fitzgerald | Cantor Fitzgerald Reiterates Overweight Rating on SI-BONE Inc. (SIBN) | $25.00 |
| Aug 6, 2024 | Needham | SI-BONE Inc. (SIBN) PT Lowered to $19 at Needham | $19.00 |
| Aug 6, 2024 | Truist Financial | SI-Bone price target lowered to $18 from $20 at Truist | $18.00 |
| Mar 28, 2024 | Piper Sandler | SI-Bone initiated with an Overweight at Piper Sandler | $25.00 |
| Jul 12, 2023 | Needham | SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches | $32.00 |
| Jan 6, 2023 | Morgan Stanley | Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18 | $18.00 |
- 6 firms rate SIBN: 6 buy, 0 hold, 0 sell.
- The average price target is $23.00 from 2 analysts, from $21.00 to $25.00.
Updated 2026-11-03 00:01 UTC